SecBot SecBot
8-K ·Filed May 5, 2026

IDYA

IDEAYA Biosciences, Inc.
NEUTRAL
Impact 2/10
Horizondays Processed6mo ago SEC0001193125-26-206806
8-K context-dependent: Items 8.01
Actionable Insight • Neutral

Monitor future ATM usage disclosures on Form 424B5 to track actual dilution. The filing itself is administrative and does not change the company's fundamental outlook. No immediate trading catalyst.

DirectionNeutral
Confidencehigh
Horizondays

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$28.74
T+0 close · May 5, 2026 · via day close
Latest settled
+23.52%
T+60 · $35.50
Vs SPY
+21.46%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · May 6 $28.74entry
  2. T+1 · 6mo ago −1.74%α −1.41% · $28.24
  3. T+5 · 6mo ago −2.16%α −3.29% · $28.12
  4. T+20 · 6mo ago −1.18%α −3.96% · $28.40
  5. T+60 · 4mo ago +23.52%α +21.46% · $35.50

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

IDEAYA Biosciences filed a new automatic shelf registration statement (Form S-3ASR) to replace its prior shelf that was expiring, and concurrently filed a prospectus supplement for its existing ATM offering with Jefferies, with $156.6 million in remaining capacity. This is a routine administrative filing to maintain financing flexibility. No financial results or material business developments were reported.

Key Facts

  • Filed new automatic shelf registration statement (S-3ASR) on May 5, 2026 to replace prior shelf expiring June 26, 2026.
  • Filed ATM prospectus supplement under existing Sales Agreement with Jefferies; up to $156,552,996.81 in common stock remains available for sale.
  • Prior to this filing, the company had already sold $193,447,003.19 under the same ATM program.
  • No financial results, guidance, or operational updates were provided in this filing.

Financial Impact

Up to $156.6 million in potential common stock issuance under ATM program, but no immediate capital raised.

dilution

Risk Factors

  • Potential dilution from future ATM sales if executed.
  • Market perception of increased share supply may pressure stock near-term.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
88% bullish (25 analysts)

Investment Themes

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001193125-26-206806
Document: d949251dex51.htm0001193125-26-206806
Document: 0001193125-26-206806-index-headers.html0001193125-26-206806
Document: 0001193125-26-206806-index.html0001193125-26-206806
Document: 0001193125-26-206806.txt0001193125-26-206806

Track record

13 reports on IDYA

Performance horizon

2 of 5 bullish or bearish reports moved the stock their way by T+5. Best: +15.66% at T+60 after the Apr 13, 2026 report. 3 of 5 went positive at some point.

Filters
  1. Nov 3, 202613d ago Institutional Cluster Neutral 3/10 Entry $31.33 to $31.75 Now $30.36 −3.10% ▲ +1.34% +1.93% vs SPY
  2. Nov 3, 202613d ago 8-K Neutral 5/10 Entry $31.33 to $31.75 Now $30.36 −3.10% ▲ +1.34% +1.93% vs SPY
  3. Oct 6, 20265w ago 144 Bearish 6/10 Entry $36.26 to $33.86 Now $30.36 +16.27% ▲ +6.62% +5.64% vs SPY
  4. Aug 4, 202614w ago 8-K Neutral 4/10 Entry $36.11 to $36.84 Now $30.36 −15.92% ▲ +2.02% +2.12% vs SPY
  5. Jun 23, 202620w ago 8-K Neutral 2/10 Entry $36.28 to $36.17 Now $30.36 −16.32% ▼ −0.30% −2.01% vs SPY
  6. Jun 10, 202622w ago 8-K Bearish 6/10 Entry $28.84 to $31.26 Now $30.36 −5.27% ▼ −8.39% −7.96% vs SPY
  7. Jun 9, 202622w ago 424B5 Bearish 6/10 Entry $27.60 to $30.57 Now $30.36 −10.00% ▼ −10.76% −7.33% vs SPY
  8. Jun 8, 202623w ago 424B5 Bearish 6/10 Entry $28.07 to $30.23 Now $30.36 −8.16% ▼ −7.70% −5.28% vs SPY
  9. Jun 3, 202623w ago 8-K Neutral 4/10 Entry $28.40 to $27.60 Now $30.36 +6.90% ▼ −2.82% +1.00% vs SPY
  10. May 5, 202627w ago 8-K Neutral 2/10 Viewing Entry $28.74 to $28.12 Now $30.36 +5.64% ▼ −2.16% −3.29% vs SPY
Showing 10 of 13

US Market Status

Market Closed · Opens Wed (10h 16m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published May 5, 2026